ISSN 2472-0429

Advances in Cancer Prevention
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • Adv Cancer Prev,
  • DOI: 10.4172/2472-0429.1000169

Anti-Cancer Drugs and their Pharmacological Formulation

Eliaz I*
Department of Integrative Oncology, Amitabha Medical Clinic and Healing Center, USA
*Corresponding Author : Eliaz I, Department of Integrative Oncology, Amitabha Medical Clinic and Healing Center, USA, Email: issaceliaz@gmail.com

Received Date: Apr 28, 2023 / Published Date: May 28, 2023

Abstract

Cancer is a class of diseases characterized by out-of-control cell growth. There are over 100 different types of cancer, and each is classified by the type of cell that is initially affected. Cancer harms the body when damaged cells divide uncontrollably to form lumps or masses of tissue called tumors. Tumours can grow and interfere with the digestive, nervous, and circulatory systems and they can release hormones that alter body function. Tumours that stay in one spot and demonstrate limited growth are generally considered to be benign. More dangerous, or malignant, tumours form when two things occur, A cancerous cell manages to move throughout the body using the blood or lymph systems, destroying healthy tissue in a process called invasion that cell manages to divide and grow, making new blood vessels to feed itself in a process called angiogenesis.

Keywords: Tumour resemblance; Scientific study; Phases of development; Metastasis; Cancerous cells; Cell proliferation

Citation: Eliaz I (2023) Anti-Cancer Drugs and their Pharmacological Formulation. Adv Cancer Prev 7: 169. Doi: 10.4172/2472-0429.1000169

Copyright: © 2023 Eliaz I. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Post Your Comment Citation
Share This Article
Recommended Conferences
Article Usage
  • Total views: 388
  • [From(publication date): 0-2023 - Nov 21, 2024]
  • Breakdown by view type
  • HTML page views: 323
  • PDF downloads: 65
Top